Acute lymphoblastic leukaemia (ALL) trial XII (joint trial with Eastern Co-operative Oncology Group - E2993)
Completed
- Conditions
- eukaemiaCancerLeukaemia
- Registration Number
- ISRCTN77346223
- Lead Sponsor
- Medical Research Council (MRC) (UK)
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 550
Inclusion Criteria
1. Adult patients between 15 and 55 years with previously untreated ALL
2. Morphological proof of ALL
3. Diagnosis has been made from bone marrow morphology with greater than 25% lymphoblasts by the French-American-British (FAB) criteria
Exclusion Criteria
1. Prior malignancy for which chemotherapy or radiotherapy have been given
2. AML, MDS or other antecedent haematological disorder or lymphoid transformation of chronic myeloid leukaemia
3. Previously treated
4. Intercurrent life threatening disease
5. Pregnant or lactating
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1. Length of survival<br>2. Relapse rates
- Secondary Outcome Measures
Name Time Method o secondary outcome measures